Nicholas Zdenkowski

1.5k total citations
59 papers, 597 citations indexed

About

Nicholas Zdenkowski is a scholar working on Oncology, General Health Professions and Cancer Research. According to data from OpenAlex, Nicholas Zdenkowski has authored 59 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 20 papers in General Health Professions and 19 papers in Cancer Research. Recurrent topics in Nicholas Zdenkowski's work include Patient-Provider Communication in Healthcare (20 papers), Breast Cancer Treatment Studies (18 papers) and Advanced Breast Cancer Therapies (13 papers). Nicholas Zdenkowski is often cited by papers focused on Patient-Provider Communication in Healthcare (20 papers), Breast Cancer Treatment Studies (18 papers) and Advanced Breast Cancer Therapies (13 papers). Nicholas Zdenkowski collaborates with scholars based in Australia, New Zealand and United States. Nicholas Zdenkowski's co-authors include Frances Boyle, Phyllis Butow, Stephanie Tesson, Alix Hall, Rob Sanson‐Fisher, Anne Herrmann, Amy Waller, Charles Douglas, Janine Lombard and John Cavenagh and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Nicholas Zdenkowski

52 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Zdenkowski Australia 15 294 192 166 115 100 59 597
Ellen G. Engelhardt Netherlands 15 260 0.9× 157 0.8× 215 1.3× 182 1.6× 133 1.3× 43 749
Rebeca Franco United States 14 243 0.8× 102 0.5× 118 0.7× 87 0.8× 69 0.7× 39 580
Patricia Commiskey United States 9 287 1.0× 218 1.1× 165 1.0× 75 0.7× 68 0.7× 21 703
Bobby Daly United States 12 314 1.1× 121 0.6× 57 0.3× 134 1.2× 69 0.7× 31 564
V. Duric Australia 11 398 1.4× 79 0.4× 129 0.8× 163 1.4× 112 1.1× 17 716
Helen Zorbas Australia 18 596 2.0× 288 1.5× 123 0.7× 210 1.8× 55 0.6× 48 1.0k
Joe‐Nat Clegg‐Lamptey Ghana 12 416 1.4× 148 0.8× 54 0.3× 133 1.2× 39 0.4× 34 690
Electra D. Paskett United States 6 576 2.0× 160 0.8× 127 0.8× 221 1.9× 63 0.6× 11 810
C. Klabunde United States 12 430 1.5× 220 1.1× 140 0.8× 62 0.5× 147 1.5× 16 767
Anna Moseley United States 11 286 1.0× 195 1.0× 72 0.4× 53 0.5× 66 0.7× 34 606

Countries citing papers authored by Nicholas Zdenkowski

Since Specialization
Citations

This map shows the geographic impact of Nicholas Zdenkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Zdenkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Zdenkowski more than expected).

Fields of papers citing papers by Nicholas Zdenkowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Zdenkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Zdenkowski. The network helps show where Nicholas Zdenkowski may publish in the future.

Co-authorship network of co-authors of Nicholas Zdenkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Zdenkowski. A scholar is included among the top collaborators of Nicholas Zdenkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Zdenkowski. Nicholas Zdenkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Agostinetto, Elisa, Georg Pfeiler, Dominik Hlauschek, et al.. (2025). Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109). ESMO Open. 10(1). 104096–104096. 1 indexed citations
4.
Zdenkowski, Nicholas, et al.. (2024). Fear of Cancer Recurrence in Differentiated Thyroid Cancer Survivors: A Systematic Review. Thyroid. 34(5). 541–558. 8 indexed citations
5.
Mann, G. Bruce, Anita Skandarajah, Nicholas Zdenkowski, et al.. (2023). Postoperative radiotherapy omission in selected patients with early breast cancer following preoperative breast MRI (PROSPECT): primary results of a prospective two-arm study. The Lancet. 403(10423). 261–270. 24 indexed citations
6.
Murray, N., Prudence A. Francis, Nicholas Zdenkowski, et al.. (2022). 91MO Randomized trial of neoadjuvant chemotherapy with or without concurrent aromatase inhibitor therapy to downstage ER+ve breast cancer: Breast Cancer Trials Group ANZ 1401 ELIMINATE trial. Annals of Oncology. 33. S164–S165. 2 indexed citations
7.
8.
Jansen, Jesse, et al.. (2021). The implementation of a decision aid for women with early-stage breast cancer considering contralateral prophylactic mastectomy: A pilot study. Patient Education and Counseling. 105(1). 74–80. 3 indexed citations
9.
Mayer, Erica L., Angela DeMichele, Miguel Martín, et al.. (2020). LBA12 PALLAS: A randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer. Annals of Oncology. 31. S1145–S1145. 23 indexed citations
10.
Low, Siew‐Kee, Peter Fox, Bavanthi Balakrishnar, et al.. (2020). Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio. The Breast. 54. 229–234. 4 indexed citations
11.
Herrmann, Anne, Alix Hall, & Nicholas Zdenkowski. (2018). Women's experiences with deciding on neoadjuvant systemic therapy for operable breast cancer: A qualitative study. Asia-Pacific Journal of Oncology Nursing. 5(1). 68–76. 10 indexed citations
12.
Jansen, Jesse, David Porter, Kelly‐Anne Phillips, et al.. (2018). Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy. The Breast. 40. 156–164. 17 indexed citations
13.
Waller, Amy, Alix Hall, Rob Sanson‐Fisher, et al.. (2017). Do medical oncology patients and their support persons agree about end‐of‐life issues?. Internal Medicine Journal. 48(1). 60–66. 6 indexed citations
14.
Herrmann, Anne, et al.. (2017). A discrete choice experiment to assess cancer patients’ preferences for when and how to make treatment decisions. Supportive Care in Cancer. 26(4). 1215–1220. 21 indexed citations
15.
16.
Zdenkowski, Nicholas, John Forbes, George Kannourakis, et al.. (2016). Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial. Annals of Oncology. 27(5). 806–812. 17 indexed citations
17.
Lombard, Janine, et al.. (2015). Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options. Supportive Care in Cancer. 24(5). 2139–2146. 33 indexed citations
18.
Wilcken, Nicholas, Nicholas Zdenkowski, Michelle White, et al.. (2014). Systemic treatment of HER2‐positive metastatic breast cancer: A systematic review. Asia-Pacific Journal of Clinical Oncology. 10(S4). 1–14. 17 indexed citations
19.
Boer, Richard de, Jane Beith, Jacquie Chirgwin, et al.. (2014). Systemic treatment of HER2+ metastatic breast cancer: Clinical conundrums and future perspectives. Asia-Pacific Journal of Clinical Oncology. 10(S4). 15–25. 1 indexed citations
20.
McCarthy, Nicole, Frances Boyle, Nicholas Zdenkowski, et al.. (2014). Neoadjuvant chemotherapy with sequential anthracycline–docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem). The Breast. 23(2). 142–151. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ellen G. Engelhardt Breakdown of academic impact, for papers by Rebeca Franco Breakdown of academic impact, for papers by Patricia Commiskey Breakdown of academic impact, for papers by Bobby Daly Breakdown of academic impact, for papers by V. Duric Breakdown of academic impact, for papers by Helen Zorbas Breakdown of academic impact, for papers by Joe‐Nat Clegg‐Lamptey Breakdown of academic impact, for papers by Electra D. Paskett Breakdown of academic impact, for papers by C. Klabunde Breakdown of academic impact, for papers by Anna Moseley
Rankless by CCL
2026